Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 3/2015

01.03.2015 | Image of the Month

68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Excerpt

A 52-year-old man who had hypoglycaemia for 8 years was found to have endogenous hyperinsulinism indicating an insulinoma. Abdominal MRI, CT perfusion, endoscopic ultrasonography, and 99mTc-HYNIC-TOC SPECT/CT were negative. Thus, the patient was referred for 68Ga-NOTA-exendin-4 PET/CT with the approval of the Institutional Review Board of our hospital. …
Literatur
1.
Zurück zum Zitat Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736–43.CrossRefPubMed Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736–43.CrossRefPubMed
2.
Zurück zum Zitat Korner M, Christ E, Wild D, Reubi JC. Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Front Endocrinol. 2012;3:158.CrossRef Korner M, Christ E, Wild D, Reubi JC. Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications. Front Endocrinol. 2012;3:158.CrossRef
3.
Zurück zum Zitat Christ E, Wild D, Forrer F, Brandle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398–405.CrossRefPubMed Christ E, Wild D, Forrer F, Brandle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398–405.CrossRefPubMed
4.
Zurück zum Zitat Sowa-Staszczak A, Pach D, Mikolajczak R, Macke H, Jabrocka-Hybel A, Stefanska A, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013;40:524–31.CrossRefPubMedCentralPubMed Sowa-Staszczak A, Pach D, Mikolajczak R, Macke H, Jabrocka-Hybel A, Stefanska A, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013;40:524–31.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, et al. Detection of metastatic insulinoma by positron emission tomography with [68Ga]exendin-4 – a case report. J Clin Endocrinol Metab. 2014;99(5):1519–24.CrossRefPubMed Eriksson O, Velikyan I, Selvaraju RK, Kandeel F, Johansson L, Antoni G, et al. Detection of metastatic insulinoma by positron emission tomography with [68Ga]exendin-4 – a case report. J Clin Endocrinol Metab. 2014;99(5):1519–24.CrossRefPubMed
Metadaten
Titel
68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake
Publikationsdatum
01.03.2015
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2015
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2946-9

Weitere Artikel der Ausgabe 3/2015

European Journal of Nuclear Medicine and Molecular Imaging 3/2015 Zur Ausgabe